Close Menu

NEW YORK ─ Mesa Biotech said on Wednesday it has received US Food and Drug Administration 510(k) clearance and a CLIA waiver for its Accula Strep A molecular test.

The firm said that its visually-read Strep A cassette, which fits in the palm of a hand, has been cleared for the detection of Group A Streptococcus bacterial nucleic acid to diagnose children and adults.

Accula Strep A uses RT-PCR to detect Strep A using throat, nasal, or nasopharyngeal swab samples and provides results in 30 minutes at the point of care, Mesa Biotech added.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.

NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.

Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.